TrialClinical pharmacokinetics2020

A Semi-Mechanistic Population Pharmacokinetic/Pharmacodynamic Model of Bortezomib in Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia.

Julie M Janssen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.